Explore

Trendline Trendline
Coral Secures $12.5M to Revolutionize Healthcare Administration with AI

Coral Secures $12.5M to Revolutionize Healthcare Administration with AI

Coral Secures $12.5M to Revolutionize Healthcare Administration with AI
Trendline Trendline
Allurion Launches Gastric Balloon System in U.S., Targets Obesity Market

Allurion Launches Gastric Balloon System in U.S., Targets Obesity Market

Allurion Launches Gastric Balloon System in U.S., Targets Obesity Market
Trendline Trendline
AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations

AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations

AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations
Trendline Trendline
Seapoint Raises €7.5M to Expand AI-Powered Financial Platform for Startups

Seapoint Raises €7.5M to Expand AI-Powered Financial Platform for Startups

Seapoint Raises €7.5M to Expand AI-Powered Financial Platform for Startups
Trendline Trendline
ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform

ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform

ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform
Trendline Trendline
ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining

ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining

ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining
Trendline Trendline
AI Investors Highlight Critical 12-Month Window for Business Exits

AI Investors Highlight Critical 12-Month Window for Business Exits

AI Investors Highlight Critical 12-Month Window for Business Exits
Trendline Trendline
Venture Capitalist Highlights Critical Timing for Startup Exits

Venture Capitalist Highlights Critical Timing for Startup Exits

Venture Capitalist Highlights Critical Timing for Startup Exits
Trendline Trendline
Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott

Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott

Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott
Trendline Trendline
Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan

Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan

Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan
Trendline Trendline
Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel

Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel

Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel
Trendline Trendline
Cursor Nears $2 Billion Funding Round at $50 Billion Valuation Amid Enterprise Growth

Cursor Nears $2 Billion Funding Round at $50 Billion Valuation Amid Enterprise Growth

Cursor Nears $2 Billion Funding Round at $50 Billion Valuation Amid Enterprise Growth